These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20973745)

  • 1. Bile acid sequestrants and diabetes: introduction and overview to the supplement.
    Jialal I
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1(Suppl 1):S1-2. PubMed ID: 20973745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
    Staels B
    Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colesevelam: a new and improved bile acid sequestrant?
    Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
    Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
    Elkeles RS
    Diabet Med; 2014 Jul; 31(7):880. PubMed ID: 24588426
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
    [No Abstract]   [Full Text] [Related]  

  • 7. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
    Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
    J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bile acid sequestrants in the management of type 2 diabetes mellitus.
    Ganda OP
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1(Suppl 1):S15-21. PubMed ID: 21034179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
    Goldfine AB; Fonseca VA
    Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
    Levy P
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.
    Henry RR; Aroda VR; Mudaliar S; Garvey WT; Chou HS; Jones MR
    Diabetes Obes Metab; 2012 Jan; 14(1):40-6. PubMed ID: 21831167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
    Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review.
    Ooi CP; Loke SC
    Diabet Med; 2014 Jan; 31(1):2-14. PubMed ID: 24024701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
    Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
    Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
    Younk LM; Davis SN
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL.
    Goldberg RB
    Curr Diab Rep; 2009 Oct; 9(5):331-2. PubMed ID: 19793501
    [No Abstract]   [Full Text] [Related]  

  • 20. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
    Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
    Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.